Penile arteries and erection

Journal of Vascular Research

Volumn 39, Issue 4, 2002, Pages 283-303

  Simonsen, Ulf ^a   García Sacristán, Albino ^b   Prieto, Dolores ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Autonomic nerves; Endothelium; Erectile dysfunction; Nitric oxide; Penile arteries

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN; CALCIUM; CARBON MONOXIDE; CYCLIC GMP; GUANYLATE CYCLASE; NEUROPEPTIDE Y; NITRIC OXIDE; NORADRENALIN; PROSTANOID; SEX HORMONE; VASOACTIVE INTESTINAL POLYPEPTIDE;

BLOOD FLOW; CALCIUM CELL LEVEL; CORPUS CAVERNOSUM; DIABETES MELLITUS; ERECTILE DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; INTERNAL ILIAC ARTERY; ISCHEMIC HEART DISEASE; NORADRENALIN RELEASE; OXYGEN TENSION; PENIS; PENIS ERECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSORY NERVE; SMOOTH MUSCLE; SYMPATHETIC NERVE; VASOCONSTRICTION; VASODILATATION;

ARTERIES; ENDOTHELIUM, VASCULAR; GONADAL STEROID HORMONES; HUMANS; IMPOTENCE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PENILE ERECTION; PENIS; RECEPTORS, ADRENERGIC, ALPHA; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASODILATION;

EID: 0036375461     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065541     Document Type: Review

References (207)

1. Evidence based assessment of erectile dysfunction
2. Hemodynamics of penile erection. III. Measurement of deep intracavernosal and sub-tunical blood flow and oxygen tension
3. Physiology of penile erection
4. Pharmacotherapy for erectile dysfunction
5. Pharmacology of penile erection
6. The biochemical and neurologic basis for the treatment of male erectile dysfunction
7. Anatomy, physiology and pathophysiology of erectile function
8. New theory on the mechanism of erection involving hitherto undescribed vessels
9. Two circulatory routes within the human corpus cavernosum penis: A scanning electron microscopic study of corrosion casts
10. Functional anatomy of cavernous helicine arterioles in potent subjects
11. Physiology of erection and pharmacological management of impotence
12. Trabecular smooth muscle modulates the capacitor function of the penis: Studies on a rabbit model
13. The mechanics of corporal veno-occlusion in penile erection: A theory on the effect of stretch-associated luminal constrictability on outflow resistance
14. Vascular reactivity to nifedipine and Ca(2+) in vitro: The role of preactivation, wall tension and geometry
15. Axial stretch modifies contractility of porcine coronary arteries by a protein kinase C-dependent mechanism
16. Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins: Occurrence and in vitro effects
17. Neurogenic contraction and relaxation of human penile deep dorsal vein
18. Comparative effects of dilator drugs on human penile dorsal artery and deep dorsal vein
19. Brain control of penile erection
20. Endothelin: Localization, synthesis, activity, and receptor types in human penile corpus cavernosum
21. + channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries
22. Gap junctions and ion channels: Relevance to erectile dysfunction
23. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection
24. Pathophysiology of erectile dysfunction: The contributions of trabecular structure to function and the role of functional antagonism
25. Sites of androgenic regulation of cavernosal blood pressure during penile erection in the rat
26. Coexistence of nitric oxide synthase, tyrosine hydroxylase and vasoactive intestinal polypeptide in human penile tissue: A triple histochemical and immunohistochemical study
27. Autonomic innervation of male reproductive genitalia
28. Electrical activity of corpus cavernosum during flaccidity and erection of the human penis: A new diagnostic method?
29. Norepinephrine involvement in penile detumescence
30. Antierectile role of the sympathetic nervous system in rats
31. Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis
32. Moxisylyte: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence
33. Adrenoreceptors in the human penis
34. Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery
35. Regulation of adrenergic activity in penile corpus cavernosum
36. Adrenoceptor-mediated regulation of the contractility in horse penile resistance arteries
37. Role for Ca2+-activated potassium channes in neurogenic contractions induced by electrical field stimulation in rat penile small arteries
38. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries
39. Receptors linked to inhibition of adenylate cyclase: An additional signaling mechanism
40. The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle
41. Combination of phentolamine and L-arginine or sildenafil synergistically improves neurogenic relaxation of rabbit corpus cavernosum smooth muscle
42. Yohimbine in erectile dysfunction: Would an orphan drug ever be properly assessed?
43. i and force in rat resistance arteries
44. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II
45. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
46. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway
47. +)-channels
48. Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y(1)-receptor in rat mesenteric small arteries
49. Effects of vasoactive intestinal peptide, peptide histidine methionine, and neuropeptide Y on intracavernous pressure in the rabbit
50. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries
51. Distribution and origin of neuropeptide Y-immunoreactive fibers in the penis of the rat
52. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum
53. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum
54. Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors
55. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum
56. Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: In vitro studies in canines
57. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction
58. The myogenic response: Established facts and attractive hypotheses
59. Cavernous oxygen tension and smooth muscle fibers: Relation and function
60. Cavernous oxygen tension in the patients with erectile dysfunction
61. O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle
62. Mammalian oxygen sensing, signalling and gene regulation
63. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression
64. Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells
65. Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia
66. Acidosis impairs rabbit trabecular smooth muscle contractility
67. Nitric oxide: A physiologic mediator of penile erection
68. Neural and endothelial nitric oxide synthase activity in rat penile erectile tissue
69. Co-localization of nitric oxide synthase and vasoactive intestinal peptide immunoreactivity in neurons of the major pelvic ganglion projecting to the rat rectum and penis
70. Differential distribution of nitric oxide synthase in neural pathways to the urogenital organs (urethra, penis, urinary bladder) of the rat
71. Nitric oxide-synthesizing neurons originating at several different levels innervate rat penis
72. Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis
73. Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase
74. Monkey corpus cavernosum relaxation mediated by NO and other relaxing factor derived from nerves
75. No colocalization of immunoreactivities for VIP and neuronal NOS, and a differential relation to cGMP-immunoreactivity in bovine penile smooth muscle
76. Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries
77. Histochemical demonstration of nerve cell bodies in the retractor penis muscle and the penile artery of the bull
78. Contraction and relaxation of the retractor penis muscle and the penile artery of the bull
79. Non-adrenergic, non-cholinergic relaxation of the bovine retractor penis muscle: Role of S-nitrosothiols
80. Neurogenic vasodilatation in isolated bovine and canine penile arteries
81. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries
82. Levels of nitric oxide metabolites do not increase during penile erection
83. Release of nitric oxide by nerve stimulation in the human urogenital tract
84. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
85. Nitric oxide release in penile corpora cavernosa in a rat model of erection
86. Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms
87. o-Phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide
88. In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery
89. Synthetic nitrovasodilators are effective, in vitro, in relaxing penile tissue from impotent men: The findings and their implications
90. Nitric oxide donor, linsidomine chlorhydrate (SIN-1), in the diagnosis and treatment of erectile dysfunction: Critical appraisal and review of the literature
91. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite
92. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice
93. 2+ influx
94. Selected contribution: Insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle
95. 2+ sensitization of contraction in vascular smooth muscle
96. Cyclic nucleotide phosphodiesterases and vascular smooth muscle
97. Cyclic nucleotide phosphodiesterases: Relating structure and function
98. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
99. Oral sildenafil in the treatment of erectile dysfunction
100. Sildenafil: A review of its use in erectile dysfunction
101. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro
102. Effects of sildenafil on human penile blood vessels
103. Effect of the selective phosphodiesterase type 5 inhibitor sildenafil on erectile dysfunction in the anesthetized dog
104. Innervation of human penile blood vessels
105. Acetylcholine as a possible neurotransmitter in penile erection
106. Parasympathetic nerves in penile erectile tissue of the rat contain choline acetyltransferase
107. Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue
108. Cholinergic neurotransmission in human corpus cavernosum. II. Acetylcholine synthesis
109. Nitric oxide mediates, and acetylcholine modulates, neurally induced relaxation of bovine cerebral arteries
110. Cholinergic modulation of non-adrenergic, non-cholinergic relaxation in isolated, small coronary arteries from lambs
111. Targeted disruption of the neuronal nitric oxide synthase gene
112. Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase
113. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat
114. Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase
115. Expression of penile neuronal nitric oxide synthase variants in the rat and mouse penile nerves
116. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells
117. Carbon monoxide: A putative neural messenger
118. The heme oxygenase system: A regulator of second messenger gases
119. Heme oxygenase 2: Endothelial and neuronal localization and role in endothelium-dependent relaxation
120. Peptidergic innervation of the human male genital tract
121. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum
122. Non-synergistic relaxant effects of vasoactive intestinal polypeptide and SIN-1 in human isolated cavernous artery and corpus cavernosum
123. Haemodynamics of pelvic nerve induced penile erection in the dog: Possible mediation by vasoactive intestinal polypeptide
124. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: A combined in vivo and immunohistochemical study
125. Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection?
126. Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle
127. Neurogenic nitric oxide mediates relaxation of canine corpus cavernosum
128. A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection
129. A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction
130. Relative contributions of ATP and noradrenaline to the nerve evoked contraction of the rabbit jejunal artery: Dependence on stimulation parameters
131. Endothelium-dependent nonadrenergic, non-cholinergic neural relaxation in guinea pig pulmonary artery
132. Involvement of ATP in the non-adrenergic non-cholinergic inhibitory neurotransmission of lamb isolated coronary small arteries
133. Calcitonin gene-related peptide: Immunohistochemical localization in, and effects on, the bovine penile artery
134. Calcitonin gene-related peptide: Possibly neurotransmitter contributes to penile erection in monkeys
135. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the feline erection model
136. Nitric oxide-mediated erectile effects of galantide but not galanin in vivo
137. Involvement of the sympathetic nervous system in the urinary bladder internal sphincter and in penile erection in the anesthetized cat
138. Beta adrenergic receptors in human cavernous tissue
139. Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection
140. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS)
141. Nitric oxide as a signaling molecule in the vascular system: An overview
142. Overview: Temporal and spatial relationships in shear stress-mediated endothelial signalling
143. +) channels
144. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone
145. Evidence for the involvement of endothelial nitric oxide synthase from smooth muscle cells in the erectile function of the human corpus cavernosum
146. Prostanoid production in rabbit corpus cavernosum. II. Inhibition by oxidative stress
147. Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery
148. Rationale for the combination of PGE(1) and S-nitroso-glutathione to induce relaxation of human penile smooth muscle
149. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors
150. Endothelium-independent relaxation induced by histamine in human dorsal penile artery
151. Prostanoid receptors: Structures, properties, and functions
152. Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells
153. Prostaglandin E1 activates the large-conductance KCa channel in human corporal smooth muscle cells
154. Characterization of prostanoid receptors regulating arterial and trabecular smooth muscle contractility
155. Pharmacological studies of human erectile tissue: Characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues
156. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle
157. Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction
158. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
159. The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience
160. Intracavernous Alprostadil Alfadex: An effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study
161. Presence of PGE1 binding determines the erectile response to PGE1
162. The third pathway: Endothelium-dependent hyperpolarization
163. Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries
164. + is an endothelium-derived hyperpolarizing factor in rat arteries
165. Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles
166. + but may be due to spread of current from the endothelium in guinea pig arterioles
167. +)-relaxation
168. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells
169. Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells
170. Actions of endothelin on isolated corpus cavernosum from rabbit and man
171. 125I]BQ-3020 binds predominantly to nerves in the bovine retractor penis muscle and penile artery
172. Possible role for endothelins in penile erection
173. Receptor-specific influence of endothelin-1 in the erectile response of the rat
174. Systemic and cavernous plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction
175. Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction
176. Andropause: A misnomer for a true clinical entity
177. Androgen replacement therapy in the aging male: A critical evaluation
178. Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat
179. Effects of castration and androgen replacement on erectile function in a rabbit model
180. Cavernosal nerve stimulation in the rat reverses castration-induced decrease in penile NOS activity
181. Adrenal control of erectile function and nitric oxide synthase in the rat penis
182. Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes
183. Androgenic maintenance of inflow and veno-occlusion during erection in the rat
184. The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat
185. Androgens modulate nitric oxide synthase messenger ribonucleic acid expression in neurons of the major pelvic ganglion in the rat
186. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum
187. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway
188. Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction
189. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels
190. The role of androgens in the erectile response: A 1999 Perspective
191. The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumescence in normal men
192. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men
193. Male sexual dysfunction associated with coronary heart disease
194. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study
195. Does severity of ischemic coronary disease correlate with erectile function?
196. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina Study
197. Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?
198. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men
199. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model
200. Prostanoid production in rabbit corpus cavernosum. I. Regulation by oxygen tension
201. Transforming growth factor-beta1 (TGF-beta1) is sufficient to induce fibrosis of rabbit corpus cavernosum in vivo
202. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
203. Corpus cavernosal relaxation in impotent men
204. Effect of aging on nitric oxide-mediated penile erection in rats
205. The penis is not protected: In hypertension there are vascular changes in the penis which are similar to those in other vascular beds
206. Morphological changes in cavernous tissue in spontaneously hypertensive rats
207. Decreased erectile function in renal hypertensive rats